Why Meth Is Different to Treat Than Opioids
For opioid use disorder, we have three FDA-approved medications that dramatically reduce cravings, block the high, and prevent overdose death. For methamphetamine use disorder, we have none. This is the single most important clinical reality of meth treatment: the work is entirely behavioral, which means the structure, intensity, and duration of therapy do more of the heavy lifting than in opioid treatment.
This is why evidence-based meth programs emphasize: (1) contingency management — immediate positive reinforcement for negative drug tests, which has the strongest evidence of any meth intervention; (2) the Matrix Model — a 16-week structured protocol combining CBT, family education, and 12-step facilitation; (3) longer stays than opioid programs typically recommend.
The Meth Crash: What Days 1–7 Look Like
Days 1–3 (Crash): Extreme fatigue, increased sleep (often 12–18 hours/day), intense depression, increased appetite. This is a neurological rebound — not psychological weakness. Medical monitoring focuses on sleep safety, hydration, and psychiatric stability.
Days 3–10 (Acute withdrawal): Anhedonia, emotional volatility, cravings, anxiety. Psychotic symptoms (if present during active use) typically decrease but can persist. This is when many people leave treatment prematurely — clinical structure matters most here.
Days 10–30 (Subacute): Cognitive function begins to return. Cravings become more episodic rather than constant. Therapy engagement improves. Contingency management reinforcement schedule is most effective.
Beyond 30 days: Sustained cognitive improvement, mood stabilization, development of new reward pathways. Research suggests dopaminergic recovery continues for 12–24 months.
Meth-Induced Psychosis and Dual Diagnosis
A significant percentage of people with meth use disorder experience psychotic symptoms — paranoia, auditory or visual hallucinations, delusions. The clinical question during inpatient admission is whether these symptoms are (a) substance-induced and will resolve with sustained abstinence, or (b) pre-existing or emerging primary psychiatric illness unmasked or worsened by meth use.
This distinction drives treatment: pure substance-induced psychosis typically resolves within days to weeks; primary psychiatric illness requires concurrent psychiatric care, antipsychotic medication, and longer-term mental health treatment. Inpatient programs with robust dual diagnosis capability are the clinical standard for meth users with psychotic symptoms.
Cognitive Behavioral Therapy Protocols for Meth
- The Matrix Model: 16-week structured outpatient or residential protocol — the most extensively studied meth intervention
- Contingency Management: Immediate, concrete rewards (vouchers, prize draws) for negative drug tests — the single strongest evidence-based meth intervention
- Cognitive Behavioral Therapy: Identifying thought patterns that precede use, building alternative coping skills
- Trauma-focused therapy: A significant subset of meth users have trauma histories — EMDR, CPT, or trauma-focused CBT address these drivers
What Inpatient Timelines Look Like — Meth vs. Other Drugs
For opioid use disorder, a 28-day inpatient stay is often clinically reasonable because MAT begins reducing cravings and preventing overdose immediately. For meth, with no medication option, the same 28 days rarely provides enough time for cognitive recovery and skill-building. Many clinicians recommend 60- or 90-day programs for moderate-to-severe meth use disorder, and insurance authorization for extended stays is typically granted when medical necessity is documented.
Get Confidential Help Now
Our placement coordinators are available 24/7 to help you find an available inpatient bed.
Call (888) 368-3288